Meeting
2024 ASCO Genitourinary Cancers Symposium
Imaging predictive biomarkers of response in patients with prostate cancer undergoing high-intensity focused ultrasound (HIFU) focal therapy.
Authors
Egesta Lopci
IRCCS - Humanitas Research Hospital, Rozzano, Italy
Egesta Lopci , Giovanni Lughezzani , Vittorio Fasulo , Davide Maffei , Alberto Saita , Paolo Casale , Roberto Peschechera , Rodolfo Hurle , Alessio Benetti , Luisa Pasini , Silvia Zandegiacomo , Marcello Rodari , Roberta Zanca , Luca Balzarini , Giorgio Ferruccio Guazzoni , Nicolo' Buffi , Massimo Lazzeri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 288)
DOI
10.1200/JCO.2024.42.4_suppl.288
Abstract #
288
Poster Bd #
M1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
64Cu-SAR-bisPSMA (PROPELLER) positron emission tomography (PET) imaging in patients with confirmed prostate cancer.
First Author: Eva Lengyelova
Poster
2024 ASCO Genitourinary Cancers Symposium
Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.
First Author: Ahmed M. Mahmoud
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of aggressive prostate cancer features on whole-mount histopathology and quantitative measures on PSMA PET.
First Author: Ida Sonni
Poster
2023 ASCO Annual Meeting
Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging.
First Author: Alberto Carretero-González